An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Cancer biodiagnostics
Antibody production, Cancer biodiagnostics, Cancer biological therapy, Cancer diagnosis, Cancer drug companies, Cancer targeted therapy, Cancer therapy, European cancer drug company, Monoclonal antibodies, Targeted therapy, Therapeutic antibodies
Last updated: 30/07/2009 10:10
Tag Cloud
Research & Development
anticorpi monoclonali
Therapeutic antibodies
Cancer diagnosis
Cancer drug companies
mediapharma l31 antibody
Monoclonal antibodies
biopharmaceutical company
Cancer biodiagnostics
Cancer therapy
antibodies monoclonal
products based on monoclonal antibodies
drug company
European cancer drug company
Cancer biological therapy
Antibody production
SP-2 0.1 mg Affinity purified
Scientific Advisory Board
pharmaceutical company
mouse monoclonal antibody
antibodies
Cancer targeted therapy
monoclonal antibodies production
Targeted therapy
cancer monoclonal companies
Subscribe to Rss Feed
ShareMediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
